Theseus is advancing cancer care by developing next-generation therapies to address treatment resistance. Leveraging the team’s deep expertise in developing targeted cancer therapies, Theseus is addressing the challenge of drug resistance by developing the next generation of tyrosine kinase inhibitors (TKIs).